Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia</title>
<author><name sortKey="Kantarjian, Hagop M" sort="Kantarjian, Hagop M" uniqKey="Kantarjian H" first="Hagop M." last="Kantarjian">Hagop M. Kantarjian</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Thomas, Xavier G" sort="Thomas, Xavier G" uniqKey="Thomas X" first="Xavier G." last="Thomas">Xavier G. Thomas</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Dmoszynska, Anna" sort="Dmoszynska, Anna" uniqKey="Dmoszynska A" first="Anna" last="Dmoszynska">Anna Dmoszynska</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Wierzbowska, Agnieszka" sort="Wierzbowska, Agnieszka" uniqKey="Wierzbowska A" first="Agnieszka" last="Wierzbowska">Agnieszka Wierzbowska</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Mazur, Grzegorz" sort="Mazur, Grzegorz" uniqKey="Mazur G" first="Grzegorz" last="Mazur">Grzegorz Mazur</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Mayer, Jiri" sort="Mayer, Jiri" uniqKey="Mayer J" first="Jiri" last="Mayer">Jiri Mayer</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Gau, Jyh Pyng" sort="Gau, Jyh Pyng" uniqKey="Gau J" first="Jyh-Pyng" last="Gau">Jyh-Pyng Gau</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Chou, Wen Chien" sort="Chou, Wen Chien" uniqKey="Chou W" first="Wen-Chien" last="Chou">Wen-Chien Chou</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Buckstein, Rena" sort="Buckstein, Rena" uniqKey="Buckstein R" first="Rena" last="Buckstein">Rena Buckstein</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Cermak, Jaroslav" sort="Cermak, Jaroslav" uniqKey="Cermak J" first="Jaroslav" last="Cermak">Jaroslav Cermak</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Kuo, Ching Yuan" sort="Kuo, Ching Yuan" uniqKey="Kuo C" first="Ching-Yuan" last="Kuo">Ching-Yuan Kuo</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Oriol, Albert" sort="Oriol, Albert" uniqKey="Oriol A" first="Albert" last="Oriol">Albert Oriol</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Ravandi, Farhad" sort="Ravandi, Farhad" uniqKey="Ravandi F" first="Farhad" last="Ravandi">Farhad Ravandi</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Faderl, Stefan" sort="Faderl, Stefan" uniqKey="Faderl S" first="Stefan" last="Faderl">Stefan Faderl</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Delaunay, Jacques" sort="Delaunay, Jacques" uniqKey="Delaunay J" first="Jacques" last="Delaunay">Jacques Delaunay</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Lysak, Daniel" sort="Lysak, Daniel" uniqKey="Lysak D" first="Daniel" last="Lysák">Daniel Lysák</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Minden, Mark" sort="Minden, Mark" uniqKey="Minden M" first="Mark" last="Minden">Mark Minden</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Arthur, Christopher" sort="Arthur, Christopher" uniqKey="Arthur C" first="Christopher" last="Arthur">Christopher Arthur</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">22689805</idno>
<idno type="pmc">4874148</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874148</idno>
<idno type="RBID">PMC:4874148</idno>
<idno type="doi">10.1200/JCO.2011.38.9429</idno>
<date when="2012">2012</date>
<idno type="wicri:Area/Pmc/Corpus">000451</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000451</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia</title>
<author><name sortKey="Kantarjian, Hagop M" sort="Kantarjian, Hagop M" uniqKey="Kantarjian H" first="Hagop M." last="Kantarjian">Hagop M. Kantarjian</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Thomas, Xavier G" sort="Thomas, Xavier G" uniqKey="Thomas X" first="Xavier G." last="Thomas">Xavier G. Thomas</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Dmoszynska, Anna" sort="Dmoszynska, Anna" uniqKey="Dmoszynska A" first="Anna" last="Dmoszynska">Anna Dmoszynska</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Wierzbowska, Agnieszka" sort="Wierzbowska, Agnieszka" uniqKey="Wierzbowska A" first="Agnieszka" last="Wierzbowska">Agnieszka Wierzbowska</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Mazur, Grzegorz" sort="Mazur, Grzegorz" uniqKey="Mazur G" first="Grzegorz" last="Mazur">Grzegorz Mazur</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Mayer, Jiri" sort="Mayer, Jiri" uniqKey="Mayer J" first="Jiri" last="Mayer">Jiri Mayer</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Gau, Jyh Pyng" sort="Gau, Jyh Pyng" uniqKey="Gau J" first="Jyh-Pyng" last="Gau">Jyh-Pyng Gau</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Chou, Wen Chien" sort="Chou, Wen Chien" uniqKey="Chou W" first="Wen-Chien" last="Chou">Wen-Chien Chou</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Buckstein, Rena" sort="Buckstein, Rena" uniqKey="Buckstein R" first="Rena" last="Buckstein">Rena Buckstein</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Cermak, Jaroslav" sort="Cermak, Jaroslav" uniqKey="Cermak J" first="Jaroslav" last="Cermak">Jaroslav Cermak</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Kuo, Ching Yuan" sort="Kuo, Ching Yuan" uniqKey="Kuo C" first="Ching-Yuan" last="Kuo">Ching-Yuan Kuo</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Oriol, Albert" sort="Oriol, Albert" uniqKey="Oriol A" first="Albert" last="Oriol">Albert Oriol</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Ravandi, Farhad" sort="Ravandi, Farhad" uniqKey="Ravandi F" first="Farhad" last="Ravandi">Farhad Ravandi</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Faderl, Stefan" sort="Faderl, Stefan" uniqKey="Faderl S" first="Stefan" last="Faderl">Stefan Faderl</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Delaunay, Jacques" sort="Delaunay, Jacques" uniqKey="Delaunay J" first="Jacques" last="Delaunay">Jacques Delaunay</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Lysak, Daniel" sort="Lysak, Daniel" uniqKey="Lysak D" first="Daniel" last="Lysák">Daniel Lysák</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Minden, Mark" sort="Minden, Mark" uniqKey="Minden M" first="Mark" last="Minden">Mark Minden</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Arthur, Christopher" sort="Arthur, Christopher" uniqKey="Arthur C" first="Christopher" last="Arthur">Christopher Arthur</name>
<affiliation><nlm:aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of Clinical Oncology</title>
<idno type="ISSN">0732-183X</idno>
<idno type="eISSN">1527-7755</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec><title>Purpose</title>
<p>This multicenter, randomized, open-label, phase III trial compared the efficacy and safety of decitabine with treatment choice (TC) in older patients with newly diagnosed acute myeloid leukemia (AML) and poor- or intermediate-risk cytogenetics.</p>
</sec>
<sec><title>Patients and Methods</title>
<p>Patients (N = 485) age ≥ 65 years were randomly assigned 1:1 to receive decitabine 20 mg/m<sup>2</sup>
per day as a 1-hour intravenous infusion for five consecutive days every 4 weeks or TC (supportive care or cytarabine 20 mg/m<sup>2</sup>
per day as a subcutaneous injection for 10 consecutive days every 4 weeks). The primary end point was overall survival (OS); the secondary end point was the complete remission (CR) rate plus the CR rate without platelet recovery (CRp). Adverse events (AEs) were recorded.</p>
</sec>
<sec><title>Results</title>
<p>The primary analysis with 396 deaths (81.6%) showed a nonsignificant increase in median OS with decitabine (7.7 months; 95% CI, 6.2 to 9.2) versus TC (5.0 months; 95% CI, 4.3 to 6.3; <italic>P</italic>
= .108; hazard ratio [HR], 0.85; 95% CI, 0.69 to 1.04). An unplanned analysis with 446 deaths (92%) indicated the same median OS (HR, 0.82; 95% CI, 0.68 to 0.99; nominal <italic>P</italic>
= .037). The CR rate plus CRp was 17.8% with decitabine versus 7.8% with TC (odds ratio, 2.5; 95% CI, 1.4 to 4.8; <italic>P</italic>
= .001). AEs were similar for decitabine and cytarabine, although patients received a median of four cycles of decitabine versus two cycles of TC. The most common drug-related AEs with decitabine were thrombocytopenia (27%) and neutropenia (24%).</p>
</sec>
<sec><title>Conclusion</title>
<p>In older patients with AML, decitabine improved response rates compared with standard therapies without major differences in safety. An unplanned survival analysis showed a benefit for decitabine, which was not observed at the time of the primary analysis.</p>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Oncol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Clin. Oncol</journal-id>
<journal-id journal-id-type="hwp">jco</journal-id>
<journal-id journal-id-type="pmc">jco</journal-id>
<journal-id journal-id-type="publisher-id">JCO</journal-id>
<journal-title-group><journal-title>Journal of Clinical Oncology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0732-183X</issn>
<issn pub-type="epub">1527-7755</issn>
<publisher><publisher-name>American Society of Clinical Oncology</publisher-name>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">22689805</article-id>
<article-id pub-id-type="pmc">4874148</article-id>
<article-id pub-id-type="publisher-id">89429</article-id>
<article-id pub-id-type="doi">10.1200/JCO.2011.38.9429</article-id>
<article-categories><subj-group subj-group-type="hwp-journal-coll"><subject>Hema13</subject>
</subj-group>
<subj-group subj-group-type="heading"><subject>ORIGINAL REPORTS</subject>
<subj-group><subject>Hematologic Malignancy</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group><article-title>Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia</article-title>
<alt-title alt-title-type="short">Decitabine <italic>v</italic>
Supportive Care or Cytarabine in Older Patients With AML</alt-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Kantarjian</surname>
<given-names>Hagop M.</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
<xref ref-type="corresp" rid="cor1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Thomas</surname>
<given-names>Xavier G.</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Dmoszynska</surname>
<given-names>Anna</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Wierzbowska</surname>
<given-names>Agnieszka</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Mazur</surname>
<given-names>Grzegorz</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Mayer</surname>
<given-names>Jiri</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Gau</surname>
<given-names>Jyh-Pyng</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Chou</surname>
<given-names>Wen-Chien</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Buckstein</surname>
<given-names>Rena</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Cermak</surname>
<given-names>Jaroslav</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Kuo</surname>
<given-names>Ching-Yuan</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Oriol</surname>
<given-names>Albert</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Ravandi</surname>
<given-names>Farhad</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Faderl</surname>
<given-names>Stefan</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Delaunay</surname>
<given-names>Jacques</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Lysák</surname>
<given-names>Daniel</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Minden</surname>
<given-names>Mark</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Arthur</surname>
<given-names>Christopher</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<aff id="aff1">Hagop M. Kantarjian, Farhad Ravandi, and Stefan Faderl, University of Texas MD Anderson Cancer Center, Houston, TX; Xavier. G. Thomas, Hôpital Edouard Herriot, Lyon, France; Anna Dmoszynska, Medical University of Lublin, Lublin; Agnieszka Wierzbowska, Medical University of Lodz, Lodz; Grzegorz Mazur, Wroclaw Medical University, Wroclaw, Poland; Jiri Mayer, University Hospital Brno; Jiri Mayer, Central European Institute of Technology, Masaryk University, Brno; Daniel Lysák, University Hospital Plzeň, Plzeň; Jaroslav Cermak, Charles University, Prague, Czech Republic; Jyh-Pyng Gau, Taipei Veterans General Hospital; Wen-Chien Chou, National Taiwan University Hospital, Taipei; Ching-Yuan Kuo, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Rena Buckstein, Odette Cancer Centre; Mark Minden, University of Toronto, Toronto, Canada; Albert Oriol, Hospital Universitari Germans Trias i Pujol, Catalunya, Spain; Jacques Delaunay, Nantes University Hospital, Nantes, France; and Christopher Arthur, Royal North Shore Hospital, St Leonards, New South Wales, Australia.</aff>
</contrib-group>
<author-notes><corresp id="cor1">Corresponding author: Hagop M. Kantarjian, MD, Department of Leukemia, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030; e-mail: <email>hkantarj@mdanderson.org</email>
.</corresp>
</author-notes>
<pub-date pub-type="ppub"><day>20</day>
<month>7</month>
<year>2012</year>
</pub-date>
<pub-date pub-type="epub"><day>11</day>
<month>6</month>
<year>2012</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>11</day>
<month>6</month>
<year>2012</year>
</pub-date>
<pmc-comment> PMC Release delay is 0 months and 0 days and was based on the
. </pmc-comment>
<volume>30</volume>
<issue>21</issue>
<fpage>2670</fpage>
<lpage>2677</lpage>
<history><date date-type="received"><day>17</day>
<month>8</month>
<year>2011</year>
</date>
<date date-type="accepted"><day>1</day>
<month>3</month>
<year>2012</year>
</date>
</history>
<permissions><copyright-statement>© 2012 by American Society of Clinical Oncology</copyright-statement>
<copyright-year>2012</copyright-year>
</permissions>
<self-uri xlink:title="pdf" xlink:type="simple" xlink:href="zlj02112002670.pdf"></self-uri>
<abstract><sec><title>Purpose</title>
<p>This multicenter, randomized, open-label, phase III trial compared the efficacy and safety of decitabine with treatment choice (TC) in older patients with newly diagnosed acute myeloid leukemia (AML) and poor- or intermediate-risk cytogenetics.</p>
</sec>
<sec><title>Patients and Methods</title>
<p>Patients (N = 485) age ≥ 65 years were randomly assigned 1:1 to receive decitabine 20 mg/m<sup>2</sup>
per day as a 1-hour intravenous infusion for five consecutive days every 4 weeks or TC (supportive care or cytarabine 20 mg/m<sup>2</sup>
per day as a subcutaneous injection for 10 consecutive days every 4 weeks). The primary end point was overall survival (OS); the secondary end point was the complete remission (CR) rate plus the CR rate without platelet recovery (CRp). Adverse events (AEs) were recorded.</p>
</sec>
<sec><title>Results</title>
<p>The primary analysis with 396 deaths (81.6%) showed a nonsignificant increase in median OS with decitabine (7.7 months; 95% CI, 6.2 to 9.2) versus TC (5.0 months; 95% CI, 4.3 to 6.3; <italic>P</italic>
= .108; hazard ratio [HR], 0.85; 95% CI, 0.69 to 1.04). An unplanned analysis with 446 deaths (92%) indicated the same median OS (HR, 0.82; 95% CI, 0.68 to 0.99; nominal <italic>P</italic>
= .037). The CR rate plus CRp was 17.8% with decitabine versus 7.8% with TC (odds ratio, 2.5; 95% CI, 1.4 to 4.8; <italic>P</italic>
= .001). AEs were similar for decitabine and cytarabine, although patients received a median of four cycles of decitabine versus two cycles of TC. The most common drug-related AEs with decitabine were thrombocytopenia (27%) and neutropenia (24%).</p>
</sec>
<sec><title>Conclusion</title>
<p>In older patients with AML, decitabine improved response rates compared with standard therapies without major differences in safety. An unplanned survival analysis showed a benefit for decitabine, which was not observed at the time of the primary analysis.</p>
</sec>
</abstract>
</article-meta>
</front>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 0004511 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 0004511 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Pmc |étape= Corpus |type= RBID |clé= |texte= }}
![]() | This area was generated with Dilib version V0.6.33. | ![]() |